Crohn's Disease and Colitis Trial, Recruiting (NCT06647615)

Crohn's Disease and Colitis Trial, Recruiting NCT06647615 Sponsor: Mayo Clinic Condition: Crohn's Disease and Colitis

Printed from Voxsanity (voxsanity.com.au) — NCT06647615 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Crohns Disease And Colitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Crohn's disease (CD) that has been confirmed through a camera examination of the gut (endoscopy) and a tissue sample (biopsy).
Your recent blood test shows a low level of inflammation (a result called C-reactive protein below 5 mg/dL).
Your recent stool test also shows a low level of gut inflammation (fecal calprotectin below 150 microg/g).
You experience abdominal (stomach) pain at least once a week.

Who may not be able to join:

Your Crohn's disease has not been confirmed by a tissue sample (biopsy).
You have a known seizure disorder (such as epilepsy).
Your symptoms are thought to be caused by another physical (organic) condition.
You have a significant problem with vision or hearing.
Your symptoms are linked to a known pelvic floor disorder.
You are currently using opioid pain medications (such as morphine, codeine, or similar drugs).
You are experiencing significant anxiety or depression, measured by a specific questionnaire score above 11 (confirm with trial site).
You are unable to understand or speak English, as the virtual reality (VR) program used in this trial is only available in English.
You are unable to actively take part in the study for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jami Kinnucan, MD, Mayo Clinic

Phone: 904-953-6970

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06647615

Sponsor: Mayo Clinic

Phase: Not Applicable

Status: Recruiting

Condition: Crohn's Disease and Colitis

Trial contact: 904-953-6970

More information: https://clinicaltrials.gov/study/NCT06647615

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Crohn's disease (CD) that has been confirmed through a camera examination of the gut (endoscopy) and a tissue sample (biopsy).
Your recent blood test shows a low level of inflammation (a result called C-reactive protein below 5 mg/dL).
Your recent stool test also shows a low level of gut inflammation (fecal calprotectin below 150 microg/g).
You experience abdominal (stomach) pain at least once a week.

Who may not be able to join:

Your Crohn's disease has not been confirmed by a tissue sample (biopsy).
You have a known seizure disorder (such as epilepsy).
Your symptoms are thought to be caused by another physical (organic) condition.
You have a significant problem with vision or hearing.
Your symptoms are linked to a known pelvic floor disorder.
You are currently using opioid pain medications (such as morphine, codeine, or similar drugs).
You are experiencing significant anxiety or depression, measured by a specific questionnaire score above 11 (confirm with trial site).
You are unable to understand or speak English, as the virtual reality (VR) program used in this trial is only available in English.
You are unable to actively take part in the study for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mayo Clinic

Registry

ClinicalTrials.gov

Start date

24 May 2024

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Improvement in abdominal pain

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov